Open AccessTime Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022)
Author(s) -
Wu Qinghua,
Chen Yang,
Li Qing,
Chen Junmeng,
Mo Junfeng,
Jin Ming,
Yang Qianzhan,
Rizzello Loris,
Tian Xiaohe,
Luo Lei
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202270127
Subject(s) - photodynamic therapy , immune checkpoint , immune system , medicine , immunotherapy , cancer research , combination therapy , immunology , chemistry , organic chemistry
Time Determines the Combined Effect In article number 2200999, Lei Luo and co‐workers reveal the importance of “time” in the combination of photodynamic therapy and immune checkpoint blocking therapy. Immune checkpoint inhibitors (red cartoon people) need to intervene at the best timing of T cell infiltration to exert the best anti‐tumor and anti‐metastatic efficacy.